Tanya Stoyanova
Stanford University
H-index: 24
North America-United States
Top articles of Tanya Stoyanova
High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker
Scientific reports
2024/1/4
UCHL1 is a molecular indicator and a therapeutic target for neuroendocrine carcinomas
Cancer Research
2024/3/22
CXCR4/CB2 heterodimer antagonizes CXCR4-mediated metastasis and tumor growth in vivo
Cancer Research
2024/3/22
CDC7 is a targetable regulator of advanced prostate cancer
Cancer Research
2024/3/22
Shiqin Liu
H-Index: 5
Busola R Alabi
H-Index: 4
En-Chi Hsu
H-Index: 11
Eva Corey
H-Index: 33
Tanya Stoyanova
H-Index: 16
Shed Trop2 drives prostate cancer progression and Trop2 is a novel tissue prognostic biomarker and a candidate urinary marker for prostate cancer
Cancer Research
2024/3/22
Co-axial hydrogel spinning for facile biofabrication of prostate cancer-like 3D models
Biofabrication
2024/2/2
UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas
Cell Reports Medicine
2024/1/19
ACAA2 is a novel molecular indicator for cancers with neuroendocrine phenotype
British Journal of Cancer
2023/11/23
Dual-inhibitory domain iCARs improve the efficiency of the AND-NOT gate CAR T strategy
Proceedings of the National Academy of Sciences
2023/11/21
Liang Wang
H-Index: 3
Zhiyuan Mao
H-Index: 1
Shiqin Liu
H-Index: 5
Qingqing Yin
H-Index: 2
Keyu Li
H-Index: 7
Tanya Stoyanova
H-Index: 16
Multimodal in vivo tracking of chimeric antigen receptor T cells in preclinical glioblastoma models
Investigative Radiology
2023
Proteomics analysis of urine and catheter-associated biofilms in spinal cord injury patients
American Journal of Clinical and Experimental Urology
2023
Volbots: Volvox Microalgae‐Based Robots for Multimode Precision Imaging and Therapy
Advanced Functional Materials
2022/12
Correlation of 68Ga-RM2 PET with postsurgery histopathology findings in patients with newly diagnosed intermediate-or high-risk prostate cancer
Journal of Nuclear Medicine
2022/12/1
Molecular mechanisms underlying the development of neuroendocrine prostate cancer
2022/11/1
Current and emerging therapies for neuroendocrine prostate cancer
2022/10/1
Shiqin Liu
H-Index: 5
Tanya Stoyanova
H-Index: 16
Naoki Matsumura1, Kazutoshi Fujita2*, Mitsuhisa Nishimoto2, Yutaka Yamamoto3, Ken Kuwahara4, Yasuharu Nagai 5, Takafumi Minami2, Yuji Hatanaka6, Masahiro Nozawa2, Yasuhiro …
Advances in Prostate Cancer: Model Systems, Molecular and Cellular Mechanisms, Early Detection, and Therapies
2022/8/8
Metastasis Model to Test the Role of Notch Signaling in Prostate Cancer
2022/6/9
Acoustic fabrication of living cardiomyocyte-based hybrid biorobots
ACS nano
2022/6/7
Protein signatures to distinguish aggressive from indolent prostate cancer
The Prostate
2022/4
SU086, an inhibitor of HSP90, impairs glycolysis and represents a treatment strategy for advanced prostate cancer
Cell Reports Medicine
2022/2/15
